287 related articles for article (PubMed ID: 21300948)
1. The role of clusterin, complement receptor 1, and phosphatidylinositol binding clathrin assembly protein in Alzheimer disease risk and cerebrospinal fluid biomarker levels.
Schjeide BM; Schnack C; Lambert JC; Lill CM; Kirchheiner J; Tumani H; Otto M; Tanzi RE; Lehrach H; Amouyel P; von Arnim CA; Bertram L
Arch Gen Psychiatry; 2011 Feb; 68(2):207-13. PubMed ID: 21300948
[TBL] [Abstract][Full Text] [Related]
2. Fine mapping of genetic variants in BIN1, CLU, CR1 and PICALM for association with cerebrospinal fluid biomarkers for Alzheimer's disease.
Kauwe JS; Cruchaga C; Karch CM; Sadler B; Lee M; Mayo K; Latu W; Su'a M; Fagan AM; Holtzman DM; Morris JC; ; Goate AM
PLoS One; 2011 Feb; 6(2):e15918. PubMed ID: 21347408
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes.
Jun G; Naj AC; Beecham GW; Wang LS; Buros J; Gallins PJ; Buxbaum JD; Ertekin-Taner N; Fallin MD; Friedland R; Inzelberg R; Kramer P; Rogaeva E; St George-Hyslop P; ; Cantwell LB; Dombroski BA; Saykin AJ; Reiman EM; Bennett DA; Morris JC; Lunetta KL; Martin ER; Montine TJ; Goate AM; Blacker D; Tsuang DW; Beekly D; Cupples LA; Hakonarson H; Kukull W; Foroud TM; Haines J; Mayeux R; Farrer LA; Pericak-Vance MA; Schellenberg GD
Arch Neurol; 2010 Dec; 67(12):1473-84. PubMed ID: 20697030
[TBL] [Abstract][Full Text] [Related]
4. Implication of common and disease specific variants in CLU, CR1, and PICALM.
Ferrari R; Moreno JH; Minhajuddin AT; O'Bryant SE; Reisch JS; Barber RC; Momeni P
Neurobiol Aging; 2012 Aug; 33(8):1846.e7-18. PubMed ID: 22402018
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of memory endophenotypes for association with CLU, CR1, and PICALM variants in black and white subjects.
Pedraza O; Allen M; Jennette K; Carrasquillo M; Crook J; Serie D; Pankratz VS; Palusak R; Nguyen T; Malphrus K; Ma L; Bisceglio G; Roberts RO; Lucas JA; Ivnik RJ; Smith GE; Graff-Radford NR; Petersen RC; Younkin SG; Ertekin-Taner N
Alzheimers Dement; 2014 Mar; 10(2):205-13. PubMed ID: 23643458
[TBL] [Abstract][Full Text] [Related]
6. Replication of CLU, CR1, and PICALM associations with alzheimer disease.
Carrasquillo MM; Belbin O; Hunter TA; Ma L; Bisceglio GD; Zou F; Crook JE; Pankratz VS; Dickson DW; Graff-Radford NR; Petersen RC; Morgan K; Younkin SG
Arch Neurol; 2010 Aug; 67(8):961-4. PubMed ID: 20554627
[TBL] [Abstract][Full Text] [Related]
7. Genetic loci associated with Alzheimer's disease and cerebrospinal fluid biomarkers in a Finnish case-control cohort.
Elias-Sonnenschein LS; Helisalmi S; Natunen T; Hall A; Paajanen T; Herukka SK; Laitinen M; Remes AM; Koivisto AM; Mattila KM; Lehtimäki T; Verhey FR; Visser PJ; Soininen H; Hiltunen M
PLoS One; 2013; 8(4):e59676. PubMed ID: 23573206
[TBL] [Abstract][Full Text] [Related]
8. Association of CLU and PICALM variants with Alzheimer's disease.
Kamboh MI; Minster RL; Demirci FY; Ganguli M; Dekosky ST; Lopez OL; Barmada MM
Neurobiol Aging; 2012 Mar; 33(3):518-21. PubMed ID: 20570404
[TBL] [Abstract][Full Text] [Related]
9. Lack of association of CR1, PICALM and CLU gene polymorphisms with Alzheimer disease in a Polish population.
Klimkowicz-Mrowiec A; Sado M; Dziubek A; Dziedzic T; Pera J; Szczudlik A; Slowik A
Neurol Neurochir Pol; 2013; 47(2):157-60. PubMed ID: 23650005
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b/C4b binding sites.
Brouwers N; Van Cauwenberghe C; Engelborghs S; Lambert JC; Bettens K; Le Bastard N; Pasquier F; Montoya AG; Peeters K; Mattheijssens M; Vandenberghe R; Deyn PP; Cruts M; Amouyel P; Sleegers K; Van Broeckhoven C
Mol Psychiatry; 2012 Feb; 17(2):223-33. PubMed ID: 21403675
[TBL] [Abstract][Full Text] [Related]
11. LACK OF ASSOCIATIONS BETWEEN CLU AND PICALM GENE POLYMORPHISMS AND ALZHEIMER'S DISEASE IN A TURKISH POPULATION.
Sen A; Arslan M; Erdal ME; Ay OI; Yilmaz SG; Kurt E; Arpaci B
Ideggyogy Sz; 2015 Mar; 68(3-4):113-20. PubMed ID: 26434199
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide association reveals genetic effects on human Aβ42 and τ protein levels in cerebrospinal fluids: a case control study.
Han MR; Schellenberg GD; Wang LS;
BMC Neurol; 2010 Oct; 10():90. PubMed ID: 20932310
[TBL] [Abstract][Full Text] [Related]
13. Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals.
Corneveaux JJ; Myers AJ; Allen AN; Pruzin JJ; Ramirez M; Engel A; Nalls MA; Chen K; Lee W; Chewning K; Villa SE; Meechoovet HB; Gerber JD; Frost D; Benson HL; O'Reilly S; Chibnik LB; Shulman JM; Singleton AB; Craig DW; Van Keuren-Jensen KR; Dunckley T; Bennett DA; De Jager PL; Heward C; Hardy J; Reiman EM; Huentelman MJ
Hum Mol Genet; 2010 Aug; 19(16):3295-301. PubMed ID: 20534741
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms of CR1, CLU and PICALM confer susceptibility of Alzheimer's disease in a southern Chinese population.
Chen LH; Kao PY; Fan YH; Ho DT; Chan CS; Yik PY; Ha JC; Chu LW; Song YQ
Neurobiol Aging; 2012 Jan; 33(1):210.e1-7. PubMed ID: 22015308
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel loci for Alzheimer disease and replication of CLU, PICALM, and BIN1 in Caribbean Hispanic individuals.
Lee JH; Cheng R; Barral S; Reitz C; Medrano M; Lantigua R; Jiménez-Velazquez IZ; Rogaeva E; St George-Hyslop PH; Mayeux R
Arch Neurol; 2011 Mar; 68(3):320-8. PubMed ID: 21059989
[TBL] [Abstract][Full Text] [Related]
16. rs3851179 Polymorphism at 5' to the PICALM Gene is Associated with Alzheimer and Parkinson Diseases in Brazilian Population.
Santos-Rebouças CB; Gonçalves AP; Dos Santos JM; Abdala BB; Motta LB; Laks J; de Borges MB; de Rosso ALZ; Pereira JS; Nicaretta DH; Pimentel MMG
Neuromolecular Med; 2017 Sep; 19(2-3):293-299. PubMed ID: 28567584
[TBL] [Abstract][Full Text] [Related]
17. Associations of polymorphisms in the candidate genes for Alzheimer's disease BIN1, CLU, CR1 and PICALM with gestational diabetes and impaired glucose tolerance.
Vacínová G; Vejražková D; Lukášová P; Lischková O; Dvořáková K; Rusina R; Holmerová I; Vaňková H; Včelák J; Bendlová B; Vaňková M
Mol Biol Rep; 2017 Apr; 44(2):227-231. PubMed ID: 28316001
[TBL] [Abstract][Full Text] [Related]
18. Role of CLU, PICALM, and TNK1 Genotypes in Aging With and Without Alzheimer's Disease.
Seripa D; Panza F; Paroni G; D'Onofrio G; Bisceglia P; Gravina C; Urbano M; Lozupone M; Solfrizzi V; Bizzarro A; Boccardi V; Piccininni C; Daniele A; Logroscino G; Mecocci P; Masullo C; Greco A
Mol Neurobiol; 2018 May; 55(5):4333-4344. PubMed ID: 28631188
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
[TBL] [Abstract][Full Text] [Related]
20. Genotype patterns at PICALM, CR1, BIN1, CLU, and APOE genes are associated with episodic memory.
Barral S; Bird T; Goate A; Farlow MR; Diaz-Arrastia R; Bennett DA; Graff-Radford N; Boeve BF; Sweet RA; Stern Y; Wilson RS; Foroud T; Ott J; Mayeux R;
Neurology; 2012 May; 78(19):1464-71. PubMed ID: 22539578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
